Back to news

IDEXX Laboratories climbs 3.3% as investors appear to refocus on growth drivers ahead of third-quarter results

Investivoq PriceTracker

IDEXX Laboratories (IDXX) is up 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear single-day catalyst is not obvious, but the move appears tied to improving sentiment around IDEXX’s veterinary diagnostics growth story ahead of its next earnings report. This could be because investors are leaning on the company’s stronger second-quarter execution, slightly higher full-year revenue outlook at the midpoint, and recent strategic updates in software and diagnostics.

Details:

  • IDEXX said it will release third-quarter 2026 financial results on November 2, which can draw renewed positioning as investors look ahead to another update.
  • In its August second-quarter release, the company reported double-digit reported revenue growth and lifted the midpoint of its 2026 revenue guidance, helped by recurring Companion Animal Group diagnostics performance.
  • IDEXX also announced the acquisition of CoVetAI in September, a deal aimed at advancing veterinary workflow intelligence and expanding its software capabilities.
  • Recent company materials have continued to emphasize new product and menu expansion opportunities, including diagnostic platform and cancer testing initiatives, which may be supporting the stock’s rebound.

    • Sources:

    IDEXX Laboratories Investor Relations, SEC, StockAnalysis

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $IDXX Insider Trading Activity

    IDXX Insider Trades

    $IDXX insiders have traded $IDXX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $IDXX stock by insiders over the last 6 months:

    • LAWRENCE D KINGSLEY sold 2,203 shares for an estimated $1,172,177

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive IDXX Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $IDXX Hedge Fund Activity

    We have seen 551 institutional investors add shares of $IDXX stock to their portfolio, and 624 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • INVESCO LTD. added 1,932,860 shares (+115.2%) to their portfolio in Q2 2026, for an estimated $1,017,534,818
    • JPMORGAN CHASE & CO added 755,791 shares (+inf%) to their portfolio in Q2 2026, for an estimated $397,878,614
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 650,429 shares (+inf%) to their portfolio in Q2 2026, for an estimated $342,411,842
    • FMR LLC added 539,667 shares (+190.7%) to their portfolio in Q2 2026, for an estimated $284,102,295
    • CAPITAL WORLD INVESTORS removed 497,851 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $262,088,680
    • FUNDSMITH LLP removed 445,899 shares (-30.4%) from their portfolio in Q2 2026, for an estimated $234,739,069
    • BAILLIE GIFFORD & CO added 353,797 shares (+inf%) to their portfolio in Q2 2026, for an estimated $186,252,892

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.